Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer

Author:

Kim Boyeon12,Park Yongjung1ORCID,Kim Banseok1,Ahn Hyo Jun1,Lee Kyung-A3,Chung Jae Eun4,Han Sang Won4

Affiliation:

1. Department of Laboratory Medicine; National Health Insurance Service Ilsan Hospital; Goyang-si Korea

2. Department of Laboratory Medicine; Severance Hospital; Yonsei University College of Medicine; Seoul Korea

3. Department of Laboratory Medicine; Gangnam Severance Hospital; Yonsei University College of Medicine; Seoul Korea

4. Department of Obstetrics and Gynecology; National Health Insurance Service Ilsan Hospital; Goyang-si Korea

Funder

National Health Insurance Service

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference21 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. National Cancer Information Center Five-year survival rate of major cancers in Korea 2016 http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040302000000

3. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients;Earle;J Natl Cancer Inst,2006

4. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals;Paulsen;Int J Gynecol Cancer,2006

5. Current initial therapy of stage III and IV ovarian cancer: challenges for managed care;Schink;Semin Oncol,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3